Abbas Mirshafiey

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Venues

Clinical and experimental pharmacology & physiology

Drug development research

Future virology

Scandinavian journal of immunology

Tehran University of Medical Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tehran University of Medical Sciences Oct 01 1991

Iran

Immunopharmacologist / full professor :: Immunology

Publications

Farzaneh Tofighi Zavareh, Abbas Mirshafiey, Reza Yazdani, Abbas Ali Keshtkar, Hassan Abolhassani, Seyed Alireza Mahdaviani, Sima Habibi, Mahsa Sohani, Nima Rezaei, Asghar Aghamohammadi
Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects. Scandinavian journal of immunology 96 (1) (2022)
Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study. Future virology (2022)
Zahra Bagherian, Abbas Mirshafiey, Monireh Mohsenzadegan, Mohammad M Farajollahi
Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors. Clinical and experimental pharmacology & physiology (2021)
Seyed Shahabeddin Mortazavi-Jahromi, Arman Ahmadzadeh, Zahra Rezaieyazdi, Mona Aslani, Saiedeh Omidian, Abbas Mirshafiey
The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients. Immunopharmacology and immunotoxicology 42 (3) (2020)
Sarvenaz Kashefi, Ramesh Omranipour, Habibollah Mahmoodzadeh, Hamid Ahmadi, Afsaneh Alikhassi, Mostafa Hosseini, Salvatore Cuzzocrea, Bernd H A Rehm, Hidenori Matsuo, Abbas Mirshafiey
A randomized, controlled, phase II clinical trial of β-D-mannuronic acid (M2000) in pre-surgical breast cancer patients at early stage (T1-T2). Clinical and experimental pharmacology & physiology 46 (6) (2020)
Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Saiedeh Omidian, Arman Ahmadzadeh, Zahra Rezaieyazdi, Abbas Mirshafiey
Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients. Drug development research 81 (3) (2019)
Zahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, Arman Ahmadzadeh, Mona Aslani, Saiedeh Omidian, Arezoo Sadoughi, Zohreh Vahidi, Mandana Khodashahi, Shazia Zamurrad, Seyed Shahabeddin Mortazavi-Jahromi, Hossein Fallahzadeh, Mostafa Hosseini, Zahra Aghazadeh, Parvin Ekhtiari, Hidenori Matsuo, Bernd H A Rehm, Salvatore Cuzzocrea, Antimo D'Aniello, Abbas Mirshafiey
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology 27 (5) (2019)
Seyed Shahabeddin Mortazavi-Jahromi, Sepideh Nazeri, Fahimeh Jafarnezhad-Ansariha, Mona Oraei, Abbas Mirshafiey
Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties. Immunologic research 67 (1) (2019)
Tahereh Bakhtiari, Afshin Ghaderi, Sayyed Reza Safaee Nodehi, Zahra Aghazadeh, Farzaneh Tofighi Zavareh, Fahimeh Jafarnezhad-Ansariha, Anis Barati, Abbas Mirshafiey
An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome. Journal of cellular physiology 234 (8) (2018)
Seyed Shahabeddin Mortazavi-Jahromi, Shahab Alizadeh, Mohammad Hassan Javanbakht, Abbas Mirshafiey
Anti-diabetic effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on insulin production, blood glucose, and inflammatory markers in the experimental diabetes model. Archives of physiology and biochemistry 125 (5) (2018)

Abbas Mirshafiey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Abbas Mirshafiey